Schedule 13D ownership disclosure

Aptose Biosciences, Inc.

Security class unavailable · CUSIP: 03835T200

Event date: 2024-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
22.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-009767
Form type
SC 13D/A
Filer
Aptose Biosciences Inc.
CIK
CIK 882361
Filed
Feb 05, 2024
Reporting period
Jan 31, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub